Fennec Pharmaceuticals (TSE:FRX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Fennec Pharmaceuticals, a specialist in pediatric ototoxicity prevention, will unveil its Q2 2024 financial results on August 13, 2024, before market opening, followed by a conference call and webcast. Additionally, the company will engage in the 2024 Wedbush PacGrow Healthcare Conference in New York.
For further insights into TSE:FRX stock, check out TipRanks’ Stock Analysis page.
